Literature DB >> 18634143

Clinical features of hemophagocytic syndrome in patients with dermatomyositis.

Nobuyuki Yajima1, Kuninobu Wakabayashi, Tsuyoshi Odai, Takeo Isozaki, Mizuho Matsunawa, Yusuke Miwa, Masao Negishi, Hirotsugu Ide, Tsuyoshi Kasama.   

Abstract

OBJECTIVE: To investigate the clinical features of patients with dermatomyositis (DM) complicated by hemophagocytic syndrome (HPS).
METHODS: Twenty-four patients diagnosed with DM and treated at our hospital between January 2002 and April 2007 were enrolled for study. Serum levels of various parameters including cytokines were determined during the active disease states.
RESULTS: Levels of serum ferritin, creatine kinase, and immune complexes were all significantly higher in all patients with HPS than in those without HPS. Levels of soluble interleukin-2 receptor, macrophage colony stimulating factor, and the chemokine CX3CL1 were significantly elevated in DM patients with HPS.
CONCLUSION: Our findings suggest that mechanisms related to both circulating immune complexes and circulating cytokines are involved in the pathogenesis of HPS complicating DM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634143

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Clinical, serologic and magnetic resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in the Japanese population.

Authors:  Shintaro Hara; Tomoko Henmi; Atsushi Kawakami; Keita Fujikawa; Hiroshi Mukae; Yuji Ishimatsu; Noriho Sakamoto; Tomoyuki Kakugawa; Kenzou Kaji; Manabu Fujimoto; Masataka Kuwana; Toshiaki Tsukada; Katsuya Satoh; Masakatsu Motomura; Mami Tamai; Hideki Nakamura; Hiroaki Ida; Tomayoshi Hayashi; Tomoki Origuchi; Katsumi Eguchi; Shigeru Kohno
Journal:  Rheumatol Int       Date:  2010-12-02       Impact factor: 2.631

Review 2.  Macrophage activation syndrome in juvenile dermatomyositis: a systematic review.

Authors:  Dimitri Poddighe; Kaisar Dauyey
Journal:  Rheumatol Int       Date:  2019-09-16       Impact factor: 2.631

3.  Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.

Authors:  Tsuyoshi Kasama; Hidekazu Furuya; Ryo Yanai; Kumiko Ohtsuka; Ryo Takahashi; Nobuyuki Yajima; Yusuke Miwa; Kazuo Kobayashi
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

4.  Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.

Authors:  Yoji Komiya; Tetsuya Saito; Fumitaka Mizoguchi; Hitoshi Kohsaka
Journal:  Intern Med       Date:  2017-12-01       Impact factor: 1.271

5.  Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.

Authors:  Yushiro Endo; Tomohiro Koga; Takahisa Suzuki; Kazusato Hara; Midori Ishida; Yuya Fujita; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Remi Sumiyoshi; Takashi Igawa; Masataka Umeda; Shoichi Fukui; Ayako Nishino; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Masataka Kuwana; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

Review 6.  Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases.

Authors:  Yoshiya Tanaka; Kana Hoshino-Negishi; Yoshikazu Kuboi; Fumitoshi Tago; Nobuyuki Yasuda; Toshio Imai
Journal:  Immunotargets Ther       Date:  2020-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.